SCHEMBL30763026

SCHEMBL30763026

CC(Oc1ccc2c(-c3ccccc3Cl)cc(=O)oc2c1)C(=O)O

nearest known ligand 0.75

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 8/20 0.75
▸ HPGD P15428 6/20 0.75
▸ KDM4E B2RXH2 6/20 0.65
▸ RECQL P46063 2/20 0.65
▸ CA9 Q16790 2/20 0.59
▸ CA12 O43570 1/20 0.59
▸ AR P10275 1/20 0.55
▸ HSD17B10 Q99714 2/20 0.51
▸ POLB P06746 1/20 0.51
▸ LMNA P02545 1/20 0.49
▸ HTT P42858 1/20 0.49
▸ USP2 O75604 1/20 0.49
▸ ALDH2 P05091 1/20 0.49
▸ IGLV6-57 P01721 1/20 0.49
▸ RAB9A P51151 1/20 0.48
▸ KCNA3 P22001 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20839066 1.00 ALDH1A1 (0.75) ALDH1A1HPGDKDM4ERECQLCA9
SCHEMBL20839468 1.00 ALDH1A1 (0.75) ALDH1A1HPGDKDM4ERECQLCA9
SCHEMBL22431787 0.89 ALDH1A1 (0.59) ALDH1A1HPGDKDM4ERECQLCA9
SCHEMBL30056759 0.89 ALDH1A1 (0.59) ALDH1A1HPGDKDM4ERECQLCA9
SCHEMBL26503495 0.89 ALDH1A1 (0.59) ALDH1A1HPGDKDM4ERECQLCA9
SCHEMBL20839103 0.88 ALDH1A1 (0.58) ALDH1A1HPGDKDM4ERECQLCA9
SCHEMBL30360898 0.88 ALDH1A1 (0.58) ALDH1A1HPGDKDM4ERECQLCA9
SCHEMBL30763061 0.88 ALDH1A1 (0.58) ALDH1A1HPGDKDM4ERECQLCA9
SCHEMBL20839101 0.88 ALDH1A1 (0.58) ALDH1A1HPGDKDM4ERECQLCA9
SCHEMBL20839425 0.88 ALDH1A1 (0.58) ALDH1A1HPGDKDM4ERECQLCA9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-111386261-B Coumarin derivatives, process for their preparation and their use in the treatment of cancer 利德发现中心有限责任公司 2024-03-22 — — CN claimed
CN-111386261-B Coumarin derivatives, process for their preparation and their use in the treatment of cancer 利德发现中心有限责任公司 2024-03-22 — — CN disclosed
Send feedback